Transmarket Holdings »

Amicus Therapeutics shares owned by Transmarket Holdings

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Transmarket Holdings from 13F filings

Historical chart of Transmarket Holdings investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Transmarket Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Transmarket Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 219k 14.46
2025-12-31 $558k 39k 14.24

More positions owned by Transmarket Holdings

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
GSK Sponsored Adr (GSK)
Ishares Tr 3 7 Yr Treas Bd (IEI)
BP Sponsored Adr (BP)
Novartis Sponsored Adr (NVS)
Aegon Amer Reg 1 Cert (AEG)
Prudential Adr (PUK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Sealed Air
Vodafone Group Sponsored Adr (VOD)
Diageo Spon Adr New (DEO)
Amicus Therapeutics (FOLD)
Spdr Series Trust State Street Spd (JNK)

View all positions for Transmarket Holdings

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
UBS Group
State Street Corporation
Vanguard Capital Management
Pentwater Capital Management
Vanguard Portfolio Management
Glazer Capital
Goldman Sachs Group
Bellevue Group
HBK Investments
Geode Capital Management
Millennium Management
Morgan Stanley
CNH Partners

View all funds holding Amicus Therapeutics